Tenon Medical, INC 10-K annual reports

Tenon Medical, Inc. reported increased revenue for 2025 but continues to face significant operating losses, a going concern doubt, and a Nasdaq delisting notice due to its low bid price.

Tenon Medical's 10-K filing reveals a focus on commercial expansion, product development, and addressing financial challenges to sustain operations and achieve profitability in the SI-Joint fusion market.

Tenon Medical, Inc.'s 10-K filing details the company's securities, financial performance, and risk factors, highlighting its focus on the Catamaran SI Joint Fusion System.